Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia

IMPORTANCE: Rituximab is an anti-CD20 chimeric antibody used in a wide variety of clinical indications. There has not been widespread adoption of consistent immune monitoring before and after rituximab therapy. However, there is a subset of patients who develop prolonged, symptomatic hypogammaglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Barmettler, Sara, Ong, Mei-Sing, Farmer, Jocelyn R., Choi, Hyon, Walter, Jolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324375/
https://www.ncbi.nlm.nih.gov/pubmed/30646343
http://dx.doi.org/10.1001/jamanetworkopen.2018.4169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324375/
https://www.ncbi.nlm.nih.gov/pubmed/30646343
http://dx.doi.org/10.1001/jamanetworkopen.2018.4169

Ejemplares similares